Literature DB >> 31153765

The extrinsic risk and its association with neural alterations in spasmodic dysphonia.

Laura de Lima Xavier1, Kristina Simonyan2.   

Abstract

INTRODUCTION: Spasmodic dysphonia (SD) is an isolated focal dystonia characterized by laryngeal spasms during voluntary voice production. Environmental factors have been assumed to play a role in SD pathophysiology; however, the exact extrinsic risk factors and their association with neural alterations remain unknown.
METHODS: A total of 186 SD patients and 85 healthy controls completed a structured 177-question survey, consisting of questions on general biographical information, medical history, symptomatology of dystonia. Data were imputed in a stepwise regression model to identify extrinsic risk factors for SD. In addition, functional MRI data from a subset of this cohort were analyzed to determine brain activation abnormalities associated with the SD extrinsic risk.
RESULTS: We found that (1) recurrent upper respiratory infections, gastroesophageal reflux, and neck trauma, all of which influence sensory feedback from the larynx, represent extrinsic risk factors, likely triggering the manifestation of SD symptoms, and (2) neural alterations in the regions necessary for sensorimotor preparation and integration are influenced by an extrinsic risk in susceptible individuals.
CONCLUSIONS: These findings provide evidence for the extrinsic risk in SD development and demonstrate the link with alterations in the sensorimotor preparatory network that collectively contribute to the multifactorial pathophysiology of SD.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Case-control study; Extrinsic risk; Laryngeal dystonia; fMRI

Mesh:

Year:  2019        PMID: 31153765      PMCID: PMC6774802          DOI: 10.1016/j.parkreldis.2019.05.034

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  29 in total

1.  Diagnostic Delays in Spasmodic Dysphonia: A Call for Clinician Education.

Authors:  Francis X Creighton; Edie Hapner; Adam Klein; Ami Rosen; Hyder A Jinnah; Michael M Johns
Journal:  J Voice       Date:  2015-04-11       Impact factor: 2.009

2.  Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia.

Authors:  Kristina Simonyan; Brian D Berman; Peter Herscovitch; Mark Hallett
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

3.  Risk and protective factors for spasmodic dysphonia: a case-control investigation.

Authors:  Kristine Tanner; Nelson Roy; Ray M Merrill; Kamille Kimber; Cara Sauder; Daniel R Houtz; Darrin Doman; Marshall E Smith
Journal:  J Voice       Date:  2010-02-19       Impact factor: 2.009

4.  Epidemiology in practice: case-control studies.

Authors:  S Lewallen; P Courtright
Journal:  Community Eye Health       Date:  1998

5.  Alcohol responsiveness in laryngeal dystonia: a survey study.

Authors:  Diana N Kirke; Steven J Frucht; Kristina Simonyan
Journal:  J Neurol       Date:  2015-05-01       Impact factor: 4.849

6.  Cortical sensorimotor alterations classify clinical phenotype and putative genotype of spasmodic dysphonia.

Authors:  G Battistella; S Fuertinger; L Fleysher; L J Ozelius; K Simonyan
Journal:  Eur J Neurol       Date:  2016-06-27       Impact factor: 6.089

7.  GNAL mutation in isolated laryngeal dystonia.

Authors:  Gregory G Putzel; Tania Fuchs; Giovanni Battistella; Estee Rubien-Thomas; Steven J Frucht; Andrew Blitzer; Laurie J Ozelius; Kristina Simonyan
Journal:  Mov Disord       Date:  2016-02-01       Impact factor: 10.338

8.  Population-based norms for the Mini-Mental State Examination by age and educational level.

Authors:  R M Crum; J C Anthony; S S Bassett; M F Folstein
Journal:  JAMA       Date:  1993-05-12       Impact factor: 56.272

Review 9.  Spasmodic dysphonia: let's look at that again.

Authors:  Thomas Murry
Journal:  J Voice       Date:  2014-06-24       Impact factor: 2.009

10.  Neural correlates of abnormal sensory discrimination in laryngeal dystonia.

Authors:  Pichet Termsarasab; Ritesh A Ramdhani; Giovanni Battistella; Estee Rubien-Thomas; Melissa Choy; Ian M Farwell; Miodrag Velickovic; Andrew Blitzer; Steven J Frucht; Richard B Reilly; Michael Hutchinson; Laurie J Ozelius; Kristina Simonyan
Journal:  Neuroimage Clin       Date:  2015-10-30       Impact factor: 4.881

View more
  6 in total

Review 1.  The Patho-Neurophysiological Basis and Treatment of Focal Laryngeal Dystonia: A Narrative Review and Two Case Reports Applying TMS over the Laryngeal Motor Cortex.

Authors:  Maja Rogić Vidaković; Ivana Gunjača; Josipa Bukić; Vana Košta; Joško Šoda; Ivan Konstantinović; Braco Bošković; Irena Bilić; Nikolina Režić Mužinić
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

2.  Neural endophenotypes and predictors of laryngeal dystonia penetrance and manifestation.

Authors:  Sanaz Khosravani; Gang Chen; Laurie J Ozelius; Kristina Simonyan
Journal:  Neurobiol Dis       Date:  2020-12-11       Impact factor: 5.996

Review 3.  Laryngeal Dystonia: Multidisciplinary Update on Terminology, Pathophysiology, and Research Priorities.

Authors:  Kristina Simonyan; Julie Barkmeier-Kraemer; Andrew Blitzer; Mark Hallett; John F Houde; Teresa Jacobson Kimberley; Laurie J Ozelius; Michael J Pitman; Robert Mark Richardson; Nutan Sharma; Kristine Tanner
Journal:  Neurology       Date:  2021-04-15       Impact factor: 11.800

4.  The large-scale structural connectome of task-specific focal dystonia.

Authors:  Sandra Hanekamp; Kristina Simonyan
Journal:  Hum Brain Mapp       Date:  2020-04-20       Impact factor: 5.038

5.  Short- and Long-term Central Action of Botulinum Neurotoxin Treatment in Laryngeal Dystonia.

Authors:  Lena C O'Flynn; Kristina Simonyan
Journal:  Neurology       Date:  2022-06-28       Impact factor: 11.800

6.  A microstructural neural network biomarker for dystonia diagnosis identified by a DystoniaNet deep learning platform.

Authors:  Davide Valeriani; Kristina Simonyan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-01       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.